Menopausal women. Unspecified menopausal and perimenopausal disorder
Conditions
Interventions
Intervention 1: Intervention group: The intervention group is candidate to receive hyosine vaginal tablets. 2 hours before the hysteroscopy procedure, two hyoscine tablets (10 mg, manufactured by Pors
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Patient's willing to participate in study Menopausal women who are planed for hysteroscopy and dilator number 4 does not pass from cervix Negative past cervical surgery Negative allergy history about Hyoscine Negative past medical history about cancers, obstructive bowel disease and cardiopulmonary disease
Exclusion criteria
Exclusion criteria: not willing to participate in study Sensitivity to hyoscine
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cervical dilation. Timepoint: 2 hours after medication. Method of measurement: bogie number 4. | — |
Secondary
| Measure | Time frame |
|---|---|
| Hyoscine side effect. Timepoint: after operation. Method of measurement: physician submission. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHanieh Najafiarab
Shahid Beheshti University of Medical Sciences
Outcome results
None listed